Sequences necessary for transduction of human endogenous retrovirus (HERV)-K con , a consensus of the HERV-K(HML-2) family, were analyzed and found to reside in the leader/gag region. They act in an orientation-dependent way and consist of at least two sites working together. Having defined these sequences, we exploited this information to produce a simple system to investigate to what extent virions of HERV-K con , murine leukemia virus, and HIV-1 have the ability to transduce each other's genomes, leading to potential contamination of gene therapy vectors.
H
uman endogenous retroviruses (HERVs) are groups of retroviral elements that infected germ cells in the past and are now part of the human genome. In several instances, HERV expression has been linked to diseases and viral particles detected in tissues (reviewed in reference 1). Of the different HERV families, HERV-K(HML-2) is believed to be the most recently acquired (1) . While many HERVs have acquired deletions and mutations rendering them defective, HERV-K113 and HERV-K115 have retained functional open reading frames (ORFs) enabling them to encode retrovirus-like particles. HIV-1 infection can activate HERV expression (reviewed in reference 2), but little is known about the packaging sequences of HERVs and their relationship to other retroviruses. This oversight may be important, as cross-packaging of other retroviral genomes into HERV-K virions upon infection has the potential to broaden their tropism. We mapped the sequences necessary for the transduction of HERV-K con as the prototypic member of the HERV-K(HML-2) family and looked for functional interactions with other retroviruses.
The generation of HERV-K con from the consensus of several HERV-K sequences and its ability to encode functional ORFs have been previously described (3) . In our experiments, we used the described system of vesicular stomatitis virus glycoprotein G (VSV-G)-pseudotyped HERV-K con particles, able to transduce CHKCG, a full-length HERV-K con vector carrying a cytomegalovirus promoter (CMV)/enhanced green fluorescent protein (eGFP) cassette in its env ORF (Fig. 1A) . The HERV-K con Gag, PR, and Pol proteins were made from expression plasmid pCVI/Gag-PR-Pol. We also included expression plasmid pCR3.1/K-Rev in the transfection cocktail, as it encodes K-Rev (or Rec), a protein involved in HERV-K con RNA export from the nucleus to the cytoplasm similar to the HIV-1 Rev protein (3). VSV-G was encoded by plasmid pMD2.G. All HERV-K con constructs were generated by standard cloning techniques and confirmed by sequencing. VSV-G-pseudotyped HERV-K con virions were prepared from transfected 293T cells by using polyethylenimine (4) . Experiments were performed in triplicate, and flow cytometry determined transfection efficiencies to be above 85% for all constructs. In all experiments, GFP-expressing colonies were scored by fluorescence microscopy on human melanoma A375 cells transduced by supernatant harvested 2 days posttransfection of 293T cells with the vectors described.
We introduced deletions into CHKCG and investigated whether the resulting vectors could transduce recipient cells (Fig.  1A) . We also generated a mutant pSTOP construct carrying a stop codon in gag after amino acid 228. In contrast to CHKCG but like the deletion mutant constructs, pSTOP needed plasmid pCVI/ Gag-PR-Pol to provide HERV-K con Gag, PR, and Pol for transduction (data not shown), allowing unbiased comparison of titers.
Compared with plasmid pSTOP, constructs p⌬1280/1799 and p⌬1083/1799 (numbers refer to positions of proviral HERV-K con DNA) carrying deletions within the gag/leader region showed a marked decrease in transduction efficiency (Fig. 1B) . In contrast, a ⌬1800/6639 deletion mutant construct transduced better than the full-length pSTOP mutant construct. These results indicate that important sequences for transduction are located before position 1800 of HERV-K con . This is in addition to the sequence between 6852 and 9472 that contains the previously identified Rec-responsive element (5), which was retained in all of the constructs.
Foamy viruses (FV) are a distinct subfamily of exogenous retroviruses (6). They are not known to express a Rev-like protein.
An FV packaging system based on the FV structural proteins Gag, Pol, and Env together with the vector p⌬⌽ has been previously described (7) . We generated the vector pFV-eGFP by PCR amplifying the spleen focus-forming virus (SFFV)-eGFP cassette (eGFP under the control of the SFFV promoter) of plasmid pMD9 (8) and inserting it as an RsrII/NotI fragment into p⌬⌽ ( Fig. 2A) . To see whether the identified HERV-K con leader/gag ORF sequences are sufficient for transduction, several fragments covering this area were PCR amplified and inserted as ClaI/RsrII fragments into pFV-eGFP. The transduction efficiencies of the resulting pFVeGFP/HERV-K con hybrid vectors were then compared with that of the original pFV-eGFP vector.
While the FV-eGFP construct containing HERV-K con nucleotides (nt) 901 to 1740 resulted in the highest transduction efficiency, constructs with shorter HERV-K con fragments were weaker but still active (Fig. 2B ), indicating that several sites act cooperatively. When present in the inverse orientation, sequence 1740/901 transduced only poorly, indicating that RNA secondary structure is important for transduction. Constructs pFVeGFP901/1740 and pFV-eGFP1740/901, which carry the cis-act- ing sequences CASI and CASII necessary for delivery by FV virions (9) , were produced to similar titers (1.7 ϫ 10 5 and 1.5 ϫ 10 5 , respectively) when tested by the FV system (7) . That inversion of the 901/1740 sequence diminished the titer in HERV-K con virions but not in FV virions (which are not dependent on a HERV-K packaging sequence) rules out the possibility of artifacts from the introduction of the inverted sequence and thus demonstrates that HERV-K con positions 901 to 1740 are necessary and sufficient to confer transduction by HERV-K con virions. The experiments also indicate that the foreign FV long terminal repeats (LTRs) are recognized and integrated into the genome by HERV-K con integrase.
While retroviral packaging sequences are generally just 300 to 400 nt long (reviewed in reference 10), at about 840 nt, the HERV-K con sequences necessary for transduction are even longer than the 624 nt previously described for Mason-Pfizer monkey virus (11) . Similar to the situation in bovine leukemia virus, where a bipartite packaging signal has been described (12), at least two regions in HERV-K con work together cooperatively for full activity.
The activation of HERV gene expression by HIV-1 has been previously reported (2) . We wanted to see whether HERV-K con virions have the ability to transduce vectors carrying packaging signals of HIV-1 and murine leukemia virus (MLV). To this end and to avoid problems that might arise from the use of different vector backbones, vector pCPX, a HERV-K con vector with a deletion between positions 989 and 6640, was generated (Fig. 3A) . Packaging sequences from HIV-1 and MLV of 310 and 304 nt, respectively, were PCR amplified and cloned as PacI/XbaI fragments into pCPX, resulting in constructs pCPX/HIV-1 and pCPX/MLV. Their transduction titers were compared, with pCPX and a ⌬1800/6639 deletion mutant construct serving as negative and positive controls, respectively. The results are shown in Fig.  3B . HERV-K con virions transduced construct pCPX/HIV-1 to about 8% of the level of the HERV-K con positive control p⌬1800/ 6639 (Fig. 3B) , whereas pCPX/MLV sequences transduced similarly to empty vector pCPX (1.6 and 1.3%, respectively). These results indicate that, provided functional HERV-K proteins are produced, some HIV-1 packaging can occur. In this light, it is interesting that a newly detected HERV-K(HML-2) provirus, termed K111, is specifically active in HIV-1-infected individuals and the presence of virus-like particles transmitting sequences to other cells has been described (13, 14) . Moreover, approaches aiming to clear HIV-1 infection should consider that some HERVs have the potential to contribute to HIV transmission yet may not be sensitive to antiretroviral therapies.
Many vectors commonly used in gene therapy experiments are based on MLV and HIV-1. We investigated the above-mentioned pCPX hybrids for transduction by MLV capsids produced from expression plasmid pCG-gagpol (15) pseudotyped with VSV-G. We found that the HERV-K con p⌬1800/6639 vector was recognized at 43% of pCPX/MLV, while pCPX/HIV-1 was transduced at only 23% (Fig. 3B) . When VSV-G-pseudotyped HIV-1 virions (generated from expression plasmid psPAX2) were used, the transduction efficiencies of p⌬1800/6639 and pCPX/MLV were 16 and 15% of that of pCPX/HIV-1, respectively (Fig. 3B) .
Since all human packaging cells lines harbor HERV-K genomes, upon activation, they might be packaged into MLV or HIV-1 virions. This could introduce new copies of endogenous retroviruses into active chromatin, the preferred integration site of lentiviral vectors (16) . Furthermore, a contaminating HERV genome would retain any LTR enhancer activity, a major contributor to genotoxicity that is exacerbated by MLV's propensity to integrate within regulatory regions and near oncogenes (16, 17) . Since there are increasing associations of HERV activation with human diseases, researchers should be alert to the risk of introducing de novo endogenous virus insertions from vectors used in human trials.
